We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Malignant Hyperthermia FREE

Janet M. Torpy, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2005;293(23):2958. doi:10.1001/jama.293.23.2958.
Text Size: A A A
Published online

Malignant hyperthermia (MH) is severe, potentially fatal increased body energy consumption after exposure to certain anesthetic drugs. Malignant hyperthermia occurs in persons who have a genetic (inherited) susceptibility to this medical problem. Family history of death during general anesthesia (being put to sleep for surgery) or having a high body temperature during or after general anesthesia are the most likely indicators that a person may be susceptible to MH. The June 15, 2005, issue of JAMA includes an article about genetic testing (DNA testing from a sample of blood or other tissue) that can detect the presence of susceptibility for MH in persons with a family history of the disorder.


It is crucial for persons who are known to have MH or who have family members with MH to inform their doctors about it, particularly if they are having any type of anesthesia or surgery. Wearing a medical alert bracelet is a helpful way to communicate this in case of an emergency, especially for children. Anesthesiologists (doctors with special training in pain control and other medical care during surgery) can prevent the triggering of MH if they know in advance of an individual's susceptibility to MH. Anesthesiologists avoid certain commonly used medications for persons with MH. These include succinylcholine (a muscle relaxant used during general anesthesia) and the volatile (inhaled) anesthetic agents. When the anesthesiologist knows in advance about a person's own or family history of MH, general or regional (such as spinal, epidural, or nerve block) anesthesia can be safely administered. For patients or professionals who have questions about MH, the Malignant Hyperthermia Association of the United States provides a 24-hour hotline: 800/644-9737.


If an MH crisis is suspected in the operating room, all triggering anesthetic agents are stopped. Dantrolene, a medication to treat MH, is given intravenously with close monitoring of breathing, heart function, and body temperature. Oxygen is provided with an increased breathing rate using a mechanical ventilator to remove excess carbon dioxide from the individual's system. Cooling techniques including cooling blankets and ice packs may be required if the patient's temperature becomes markedly elevated. Medications to control blood pressure or treat abnormal heart rhythms may also be needed.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.

Sources: American Society of Anesthesiologists, Malignant Hyperthermia Association of the United States

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Collections
PubMed Articles